These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22892605)

  • 1. Prospective audit of post-chemotherapy febrile neutropenia in patients with solid cancer and lymphoma in two Singaporean cancer centres.
    Wong M; Jin J; Tan MH; Lee YM; Lee TE; Ding Y; Yong HC; Lim SE; Chai LY; Chau NM; Hsu LY
    Ann Acad Med Singap; 2012 Jul; 41(7):287-93. PubMed ID: 22892605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and clinical course of febrile neutropenia in children with cancer.
    Hakim H; Flynn PM; Knapp KM; Srivastava DK; Gaur AH
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):623-9. PubMed ID: 19644403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre.
    Schelenz S; Giles D; Abdallah S
    Ann Oncol; 2012 Jul; 23(7):1889-93. PubMed ID: 22048152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of febrile neutropenia in adult patients with hematologic neoplasms in a period of 26 months in Hospital Pablo Tobón Uribe, Colombia].
    Madrid C; Díaz L; Combariza J; Gálvez K; Olaya V; Ramírez I; Donado J
    Rev Chilena Infectol; 2013 Apr; 30(2):195-201. PubMed ID: 23677158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs associated with febrile neutropenia in solid tumor and lymphoma patients - an observational study in Singapore.
    Wang XJ; Wong M; Hsu LY; Chan A
    BMC Health Serv Res; 2014 Sep; 14():434. PubMed ID: 25252614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective audit of febrile neutropenia management at a tertiary university hospital in Singapore.
    Jin J; Lee YM; Ding Y; Koh LP; Lim SE; Lim R; Tambyah PA; Hsu LY
    Ann Acad Med Singap; 2010 Jun; 39(6):453-9. PubMed ID: 20625621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
    Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
    Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality, length of stay, and cost associated with hospitalized adult cancer patients with febrile neutropenia.
    Chindaprasirt J; Wanitpongpun C; Limpawattana P; Thepsuthammarat K; Sripakdee W; Sookprasert A; Wirasorn K
    Asian Pac J Cancer Prev; 2013; 14(2):1115-9. PubMed ID: 23621197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of febrile neutropenia in patients receiving chemotherapy for solid tumors: a retrospective study of twenty cases from the radiotherapy centre, Accra, Ghana.
    Vanderpuye V; Yarney J; Beecham K
    West Afr J Med; 2010; 29(5):303-8. PubMed ID: 21089015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs associated with febrile neutropenia in the US.
    Michels SL; Barron RL; Reynolds MW; Smoyer Tomic K; Yu J; Lyman GH
    Pharmacoeconomics; 2012 Sep; 30(9):809-23. PubMed ID: 22804805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA.
    Freifeld A; Sankaranarayanan J; Ullrich F; Sun J
    Support Care Cancer; 2008 Feb; 16(2):181-91. PubMed ID: 17943327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
    Poon LM; Jin J; Chee YL; Ding Y; Lee YM; Chng WJ; Chai LY; Tan LK; Hsu LY
    Singapore Med J; 2012 Nov; 53(11):720-5. PubMed ID: 23192498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
    Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
    Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An audit of febrile neutropenia cases from a rural cancer center in India.
    Patil VM; Chakarborty S; Kumar MS; Geetha M; Dev S; Samuel S; Ahmed G; Nayanar SK; Vineetha R; Nair CK
    Indian J Cancer; 2014; 51(4):487-90. PubMed ID: 26842173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Consensus: Rational approach towards the patient with cancer, fever and neutropenia].
    Santolaya ME; Rabagliati R; Bidart T; Payá E; Guzmán AM; Morales R; Braun S; Bronfman L; Ferrés M; Flores C; García P; Letelier LM; Puga B; Salgado C; Thompson L; Tordecilla J; Zubieta M; ;
    Rev Chilena Infectol; 2005; 22 Suppl 2():S79-113. PubMed ID: 16311689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-risk febrile neutropenia in a medical oncology unit.
    Leong DC; Kinlay S; Ackland S; Bonaventura A; Stewart JF
    Aust N Z J Med; 1997 Aug; 27(4):403-7. PubMed ID: 9448881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
    Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
    Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.